Cuprior® 150 mg Film-Coated Tablets
Cuprior® is available in the EU, UK, Colombia, Saudi Arabia and New Zealand. Cuprior® is marketed as Cuvrior® in the US and Ku Pei Ou® in China.
Our Products
Innovative treatments for rare diseases
Each of our therapies is the result of research and clinical development, addressing areas where treatment options for patients with rare diseases remain limited.
Our Therapeutic Portfolio
Two approved treatments across different rare disease areas
Wilson's Disease
Kigabeq® 100 mg and 500 mg Scored Soluble Tablets
Kigabeq® (EU).
Medical Information Requests
For clinical data, dosing guidance and safety information on any Orphalan product
Backed by Clinical Evidence
All our products have undergone clinical development and are supported by safety and efficacy data reviewed by regulatory authorities.
Clinical Trials
Comprehensive clinical development programs
Publications
Peer-reviewed scientific publications
Years of Data
Long-term safety and efficacy information